Events and meetings

OICR BioLab Training

The training sessions offered by BioLab foster collaboration in the cancer research community and provide a place to share experiences, build new collaborations and drive cancer research forward.


MACSQuant® Tyto® Flow Cell Sorter for Multiparametric Cell Sorting Based on Microchip Technology for Sterile and Gentle Cell Isolation

cell-sortingOver the years researchers have been looking to improve results of flow cell sorting via improving cell viability and functionality while retaining a GMP environment. Miltenyi Biotec, world leader in flow cytometry, now offers an opportunity to expand cell sorting capabilities with innovative microchip-based technology of the MACSQuant®Tyto® Flow Cell Sorter. This unique feature opens up new possibilities in basic research and medical applications by offering high-speed multiparameter sorting and complete cell retrieval in fully enclosed sterile environment.

Learning objectives:

  • Traditional “jet-in-air” vs. valve-based microchip-based sorting techniques;
  • Expanded applications in flow cell sorting;
  • Case studies.

Presenter: Michela Hirnak, Application Scientist, Miltenyi Biotec Inc.
Date: April 17, 2019, from 2-3 p.m.
Where: BR 6-11/12, 6th Floor West Tower, OICR​

Register at eventbrite


Optimizing Ribonucleoprotein Delivery to Achieve Potent and Precise CRISPR/Cas9 Genome Editing

cas-9 ImageThe seminar will present the Alt-R® CRISPR genome editing platform developed by Integrated DNA Technologies (IDT) as a potent genome editing tool that combines the precision of chemically synthesized guide RNAs with a high performance Cas9 protein.

The Alt-R ®CRISPR-Cas9 system offers powerful, non-toxic on-target editing, reduced off-target effects and it is easy to deliver into a wide array of cells.

Learning objectives:

  • update on the latest improvements in on- and off-target design and chemical modifications, custom or predesigned guide RNAs;
    introduction of novel high-fidelity Cas9 mutant for reduced off-target gene editing;
  • guidelines on the use of gRNA in the context of Cas9 source (plasmid, mRNA, ribonucleoprotein complex, cell type).

Presenter: Branimir Bugarija, Genomics Application Scientist, Integrated DNA Technologies
Date: March 27, 2019, from 2-3 p.m.
Where: BR 6-11/12, 6th Floor West Tower, OICR

Register at eventbrite​